Using artificial cell-like particles, Yale biomedical engineers have devised a way to produce a 45-fold enhancement of T cell activation and expansion, an immune response important for a patient’s…

LAUSANNE, Switzerland and NEWTOWN, Pennsylvania, February 26 /PRNewswire/ -- - Products and Pipeline to Enhance Galderma's Position in Dermatology Galderma Pharma S.A., a global specialty…

The case of a 47 year-old woman presenting a wide abdominal zone with vitiligo like hypopigmentation is reported. In 1977 she underwent, in the same site, melanoma (III Clarke's level) extirpation…

STAINES, England, February 22 /PRNewswire/ -- - New Treatment Option Contributes to Fight Against Healthcare Associated Infections Astellas Pharma Europe Ltd(i) announced today that the Committee…

INDIANAPOLIS, February 22 /PRNewswire/ -- - If approved, bone formation agent for osteoporosis would be available for new patient population Eli Lilly and Company (NYSE: LLY) today announced that…

Expressive writing --writing about one’s deepest thoughts and feelings—may help change the way cancer patients think and feel about their disease. In one of the first studies published in an…

COPENHAGEN, Denmark and REDWOOD CITY, California, February 21 /PRNewswire/ -- - Summary: Genmab and PDL BioPharma Have Entered into an Agreement Under Which Genmab Will Acquire PDL's Antibody…

REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, February 21 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release fourth quarter financial results on February 29, 2007,…

Researchers at Dana-Farber Cancer Institute have found a previously unknown molecular pathway in mice that spurs the growth of new blood vessels when body parts are jeopardized by poor circulation.…

HALIFAX, England, February 20 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today the appointment of former senator, Michael Kirby, as the new Board…